KAJT Biotech AB

Active
559408-9293Limited company (AB)Registered 2022LIMHAMN

Key figures

43 500 kr−64,2%
Revenue 2024/25
−54,0%
Average annual change 2022/23–2024/25
0100 k200 k300 k2022/232023/242024/25

Key figures

2024/25

Summary: KAJT Biotech AB

What kind of company is it?

KAJT Biotech AB (org. no. 559408-9293) is a limited company (AB). The company was registered in 2022 and has existed for 3 years. Registered seat: Limhamn. Industry according to Statistics Sweden: business and other management consultancy activities (SNI 70200).

How is the company doing financially?

Net sales in financial year 2025 were 43 500 kr, down 64,2 % on the previous year (121 501 kr). From 2023 to 2025, net sales declined by an average of 54,0 % per year. Net profit for 2025 was 25 055 kr (57,6 % of net sales). The company was profitable in 2 of the 3 reported financial years. At the end of financial year 2025, total assets were 196 340 kr and equity 126 719 kr (equity ratio 64,5 %).

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 2 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Summary of annual reports2023–2025
2022/232023/242024/25
Sales revenue205 501121 50143 500
Profit for the reporting year118 072−41 40825 055
Retained earnings of previous periods———
Total assets260 741196 031196 340
Total liabilities117 66994 36769 621
Total equity143 072101 664126 719
Employees———

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.